Page last updated: 2024-08-23

simvastatin and Eye Cancer, Retinoblastoma

simvastatin has been researched along with Eye Cancer, Retinoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
He, F; Jiang, Y; Li, J; Li, P; Liang, Z; Liu, J; Liu, P; Luo, Z; Ren, Y; Vaziri, C; Wang, B; Wang, Y; Yang, J; Yang, L; Zhang, J; Zhou, C	1

Other Studies

1 other study(ies) available for simvastatin and Eye Cancer, Retinoblastoma

Article	Year
Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth. Cell death & disease, 2017, 03-16, Volume: 8, Issue:3 Topics: Animals; Atorvastatin; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; DNA Replication; Humans; Mice; Minichromosome Maintenance Complex Component 7; Retinoblastoma; Retinoblastoma Protein; Simvastatin	2017

Article

Year

Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth.

Cell death & disease, 2017, 03-16, Volume: 8, Issue:3

Topics: Animals; Atorvastatin; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; DNA Replication; Humans; Mice; Minichromosome Maintenance Complex Component 7; Retinoblastoma; Retinoblastoma Protein; Simvastatin

2017